SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-235110
Filing Date
2015-06-25
Accepted
2015-06-25 16:06:38
Documents
8
Period of Report
2015-07-23
Effectiveness Date
2015-06-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d880101ddef14a.htm DEF 14A 809133
2 GRAPHIC g880101g23b86.jpg GRAPHIC 32404
3 GRAPHIC g880101g69j28.jpg GRAPHIC 26969
4 GRAPHIC g880101g77y10.jpg GRAPHIC 34316
5 GRAPHIC g880101g82d33.jpg GRAPHIC 30810
6 GRAPHIC g880101g94s27.jpg GRAPHIC 62384
7 GRAPHIC g880101g96o03.jpg GRAPHIC 69330
8 GRAPHIC g880101pc_pg1.jpg GRAPHIC 5190
  Complete submission text file 0001193125-15-235110.txt   1171354
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36172 | Film No.: 15951903
SIC: 2836 Biological Products, (No Diagnostic Substances)